These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

100 related articles for article (PubMed ID: 6986799)

  • 1. Maintenance therapy with amitriptyline: a controlled trial.
    Stein MK; Rickels K; Weise CC
    Am J Psychiatry; 1980 Mar; 137(3):370-1. PubMed ID: 6986799
    [No Abstract]   [Full Text] [Related]  

  • 2. Viloxazine and amitriptyline in depressive illness. A double blind controlled trial in general practice.
    Lennox IG; Asbury JF; Couldrick WG; Beswick KB
    Practitioner; 1978 Jan; 220(1315):153-6. PubMed ID: 343090
    [No Abstract]   [Full Text] [Related]  

  • 3. Doctor-patient concordance in a placebo-controlled trial of limbitrol versus its components [proceedings].
    Jacobson AF
    Psychopharmacol Bull; 1978 Jul; 14(3):61-3. PubMed ID: 353872
    [No Abstract]   [Full Text] [Related]  

  • 4. Clinical evaluation of the antidepressants: maprotiline and amitriptyline. A double-blind controlled trial.
    Marais GF
    S Afr Med J; 1974 Jul; 48(36):1530-2. PubMed ID: 4608286
    [No Abstract]   [Full Text] [Related]  

  • 5. Differential effects on suicidal ideation of mianserin, maprotiline and amitriptyline.
    Montgomery S; Cronholm B; Asberg M; Montgomery DB
    Br J Clin Pharmacol; 1978; 5 Suppl 1(Suppl 1):77S-80S. PubMed ID: 341948
    [No Abstract]   [Full Text] [Related]  

  • 6. Three double-blind comparative trials of mianserine (ORG GB 94) and amitriptyline in the treatment of depressive illness.
    Jaskari MO; Ahfors UG; Ginman L; Lydekcne K; Tienari P
    Pharmakopsychiatr Neuropsychopharmakol; 1977 Mar; 10(2):101-3. PubMed ID: 360231
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Double-blind study of the therapeutic efficacy and tolerability of amitriptylinoxide in comparison with amitriptyline.
    Tegeler J; Klieser E; Lehmann E; Heinrich K
    Pharmacopsychiatry; 1990 Jan; 23(1):45-9. PubMed ID: 2179974
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Therapy for psychotic and psychoneurotic depression with thiothixene and perphenazine-amitriptyline (a double-blind clinical study).
    McLaughlin BE
    Dis Nerv Syst; 1969 Feb; 30(2):Suppl:85-8. PubMed ID: 4886995
    [No Abstract]   [Full Text] [Related]  

  • 9. Treatment of endogenous depression with oral thyrotropin-releasing hormone and amitriptyline.
    Karlberg BE; Kjellman BF; Kågedal B
    Acta Psychiatr Scand; 1978 Nov; 58(5):389-400. PubMed ID: 102114
    [No Abstract]   [Full Text] [Related]  

  • 10. Fluotracen (SKF 28, 175): a new antidepressant. Double-blind study with amitriptyline.
    Feldmann HS; Denber HC
    Prog Neuropsychopharmacol; 1980; 4(1):51-6. PubMed ID: 6996019
    [No Abstract]   [Full Text] [Related]  

  • 11. A comparative study of fluphenazine-amitriptyline combination and amitriptyline alone in the treatment of depressed psychiatric patients.
    Ota KY; Turek I; Berman SA; Kurland AA
    Curr Ther Res Clin Exp; 1970 Sep; 12(9):585-93. PubMed ID: 4989689
    [No Abstract]   [Full Text] [Related]  

  • 12. A controlled double-blind clinical trial between maprotiline and amitriptyline in depressive illness.
    Okasha A; Sadek A
    J Egypt Med Assoc; 1976; 59(5-6):557-62. PubMed ID: 801741
    [No Abstract]   [Full Text] [Related]  

  • 13. A double-blind comparison between amoxapine and amitriptyline in depressed in-patients.
    Kaumeier HS; Haase HJ
    Int J Clin Pharmacol Ther Toxicol; 1980 Apr; 18(4):177-84. PubMed ID: 7380591
    [No Abstract]   [Full Text] [Related]  

  • 14. A double-blind, comparative clinical trial with ludiomil (CIBA 34,276-Ba) and amitriptyline in newly admitted depressed patients.
    Amin M; Brahm E; Bronheim LA; Klingner A; Ban TA; Lehmann HE
    Curr Ther Res Clin Exp; 1973 Oct; 15(10):691-9. PubMed ID: 4201313
    [No Abstract]   [Full Text] [Related]  

  • 15. WA 335 (danitracen): a preliminary evaluation of a potential antidepressant compound. A comparative double-blind study with WA 335 and amitriptyline in the treatment of depressive patients.
    Kaumeier S; Dohren J; Flach D
    Curr Ther Res Clin Exp; 1977 Jan; 21(1):108-13. PubMed ID: 401705
    [No Abstract]   [Full Text] [Related]  

  • 16. A controlled double-blind study of femoxetine and amitriptyline in patients with endogenous depression.
    Reebye PN; Yiptong C; Samsoon J; Schulsinger F; Fabricius J
    Pharmacopsychiatria; 1982 Sep; 15(5):164-9. PubMed ID: 6757983
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Dibenzepin and amitriptyline in depressive states: comparative double-blind trial.
    Gowardman M; Brown RA
    N Z Med J; 1976 Mar; 83(560):194-7. PubMed ID: 6928
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Chronic depression: response to amitriptyline after discontinuation.
    Harkness L; Giller EL; Bialos D; Waldo MC
    Biol Psychiatry; 1982 Aug; 17(8):913-7. PubMed ID: 6810962
    [No Abstract]   [Full Text] [Related]  

  • 19. Maprotiline and amitriptyline in the treatment of depressive illness. A double-blind comparison.
    Levin A
    S Afr Med J; 1974 Jan; 48(2):47-9. PubMed ID: 4595136
    [No Abstract]   [Full Text] [Related]  

  • 20. A comparative, multicenter trial between bromocriptine and amitriptyline in the treatment of endogenous depression.
    Theohar C; Fischer-Cornelssen K; Brosch H; Fischer EK; Petrovic D
    Arzneimittelforschung; 1982; 32(7):783-7. PubMed ID: 6751339
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.